Need for Public Health Messaging Related to Bladder Health from Adolescence to Advanced Age
Burgio K, Cunningham S, Newman D, Low L, Nodora J, Lipman T, Gahagan S, Klusaritz H, James A, Rickey L, Kenton K, Hebert-Beirne J, Williams B, Brubaker L, Acevedo-Alvarez M, M. Fitzgerald C, T. Hardacker C, Lavender M, Geynisman-Tan J, W. Griffith J, Simon M, D. Markland A, Coyne-Beasley T, E. Lewis C, McGwin G, P. Vaughan C, S. Lukacz E, Gahagan S, LaCoursiere D, M. Miller J, L. Harlow B, D. Rudser K, S. Brady S, Chu H, S. Fok C, Scal P, Rockwood T, L. Smith A, Berry A, Klusaritz H, E. Stapleton A, F. Wyman J, Sutcliffe S, S. James A, L. Lowder J, R. Meister M, A. Brault M, R. Camenga D, Brubaker L, Barthold J. Need for Public Health Messaging Related to Bladder Health from Adolescence to Advanced Age. Journal Of Women's Health 2022, 32: 224-238. PMID: 36454206, PMCID: PMC9940805, DOI: 10.1089/jwh.2022.0185.Peer-Reviewed Original ResearchConceptsBladder healthPublic health messagingAge groupsHealth messagingPriority audienceIndividual prevention strategiesPublic healthAdvanced agePrevention strategiesUniform desireRisk statusLife courseHealthFocus group dataAgeStudy of habitsAdult women's experiencesFocus groupsMore researchWomen's experiencesGroupGroup dataParticipantsBladderSymptomsMedical Therapy with Antimuscarinics and ß3-Agonists
Goodridge S, Rickey L. Medical Therapy with Antimuscarinics and ß3-Agonists. 2022, 147-164. DOI: 10.1007/978-3-030-84352-6_8.Peer-Reviewed Original ResearchOveractive bladderManagement of OABTreatment of OABMedical therapy optionsSecond-line therapyFirst-line treatmentSide effect profileBeta-3 agonistQuality of lifeMedical therapyEffect profileTherapy optionsDrug classesComparative efficacyBehavioral modificationAntimuscarinicsBladderTherapyEfficacyTreatmentPharmacotherapyPatientsAgonistsLarge subsetProgression